000 01162 a2200301 4500
005 20250516231625.0
264 0 _c20150608
008 201506s 0 0 eng d
022 _a2476-762X
024 7 _a10.7314/apjcp.2014.15.16.6679
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuo, Lin-Jie
245 0 0 _aSomatostatin analogues do not prevent carcinoid crisis.
_h[electronic resource]
260 _bAsian Pacific journal of cancer prevention : APJCP
_c2014
300 _a6679-83 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aHumans
650 0 4 _aIntestine, Small
_xpathology
650 0 4 _aMalignant Carcinoid Syndrome
_xdrug therapy
650 0 4 _aNeuroendocrine Tumors
_xdrug therapy
650 0 4 _aOctreotide
_xtherapeutic use
650 0 4 _aPeptides, Cyclic
_xtherapeutic use
650 0 4 _aRespiratory System
_xpathology
650 0 4 _aSomatostatin
_xanalogs & derivatives
700 1 _aTang, Cheng-Wei
773 0 _tAsian Pacific journal of cancer prevention : APJCP
_gvol. 15
_gno. 16
_gp. 6679-83
856 4 0 _uhttps://doi.org/10.7314/apjcp.2014.15.16.6679
_zAvailable from publisher's website
999 _c24141680
_d24141680